Freenome, Inc. operates as a biotechnology company. It engages in the development of an early cancer detection platform. The company was founded in 2014 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
3
Frequently Asked Questions
What is Market Cap of Freenome Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Freenome Inc. market cap is $1.32B.
What is the 52-week high for Freenome Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Freenome Inc. 52 week high is $14.47 as of August 13, 2026.
What is the 52-week low for Freenome Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Freenome Inc. 52 week low is $9.95 as of August 13, 2026.
What is Freenome Inc. stock price today?
Freenome Inc. stock price today is $11.55.
What was Freenome Inc. stock price yesterday?
Freenome Inc. stock price yesterday was $12.00.
What is the PE ratio of Freenome Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Freenome Inc.'s P/E ratio is -165.71.
What is the Price-to-Book ratio of Freenome Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Freenome Inc. P/B ratio is 1.5126.
What is the 50-day moving average of Freenome Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Freenome Inc. 50-day moving average is $11.26.